. Author manuscript; available in PMC: 2015 Aug 15.

Published in final edited form as: Clin Cancer Res. 2014 Jun 9;20(16):4176–4185. doi: 10.1158/1078-0432.CCR-13-2024

Table 5.

Overall survival statistics for advanced pancreatic cancer according to sex and performance status.

	Female				Male
	N	6 Month / 12 Month Overall Survival Rates		Median OS Months (95% CI)	N	6 Month / 12 Month Overall Survival Rate		Median OS Months (95% CI)
	N	Predicted^*	Observed	Median OS Months (95% CI)	N	Predicted^*	Observed	Median OS Months (95% CI)
P.S. 0	130	61% / 26%	64% / 30%	7.62 (6.41 – 9.4)	158	60% / 20%	57% / 17%	6.65 (5.91 – 7.2)
P.S. 1	286	47% / 18%	45% /16%	5.37 (5.06 – 6.05)	326	46% /14%	47% / 16%	5.73 (4.76 – 6.34)
P.S. 2	68	27% / 4.0%	26% / 4.4%	3.81 (2.66 – 4.86)	78	26% / 2.9%	27% 2.6%	2.51 (1.71 - 3.25)

Predicted rates are conditional on the levels of the covariates (sex and performance status) ad are derived from a logistic regression model.